These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations. Itteboina R; Ballu S; Sivan SK; Manga V J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140 [TBL] [Abstract][Full Text] [Related]
23. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related]
24. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking. Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866 [TBL] [Abstract][Full Text] [Related]
26. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models. Tong L; Guo L; Lv X; Li Y J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025 [TBL] [Abstract][Full Text] [Related]
27. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor. Chitta A; Jatavath MB; Fatima S; Manga V J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569 [TBL] [Abstract][Full Text] [Related]
28. Design of novel FLT-3 inhibitors based on dual-layer 3D-QSAR model and fragment-based compounds in silico. Shih KC; Lin CY; Chi HC; Hwang CS; Chen TS; Tang CY; Hsiao NW J Chem Inf Model; 2012 Jan; 52(1):146-55. PubMed ID: 22142286 [TBL] [Abstract][Full Text] [Related]
29. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745 [TBL] [Abstract][Full Text] [Related]
30. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors. Vyas VK; Ghate M SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018 [TBL] [Abstract][Full Text] [Related]
31. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376 [TBL] [Abstract][Full Text] [Related]
32. Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors. Sivan SK; Manga V J Mol Model; 2012 Feb; 18(2):569-82. PubMed ID: 21547550 [TBL] [Abstract][Full Text] [Related]
33. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726 [TBL] [Abstract][Full Text] [Related]
34. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. Pirhadi S; Ghasemi JB Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190 [TBL] [Abstract][Full Text] [Related]
35. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach. Sharma MC Interdiscip Sci; 2016 Mar; 8(1):11-22. PubMed ID: 26205198 [TBL] [Abstract][Full Text] [Related]
37. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors. Hu X; Stebbins CE Bioorg Med Chem; 2005 Feb; 13(4):1101-9. PubMed ID: 15670918 [TBL] [Abstract][Full Text] [Related]
38. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs. Wu HQ; Yao J; He QQ; Chen FE SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254 [TBL] [Abstract][Full Text] [Related]
39. 3D-QSAR and molecular docking studies of 1,3,5-triazene-2,4-diamine derivatives against r-RNA: novel bacterial translation inhibitors. Sekhar YN; Nayana MR; Sivakumari N; Ravikumar M; Mahmood SK J Mol Graph Model; 2008 Jun; 26(8):1338-52. PubMed ID: 18372201 [TBL] [Abstract][Full Text] [Related]
40. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors. Chaudhaery SS; Roy KK; Saxena AK J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]